Importantly, the loss of BRCA1 expression was found to be significantly associated with DGC, a higher tumor grade, advanced clinical stage, and a lower 2-year survival rate compared to patients with positive BRCA1 expression [33]. Here, BRCA1 is linked to neoplasm.